News
-
-
PRESS RELEASE
BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
BRAIN Biotech's Q1 25/26 results show revenue decline but improved EBITDA. Breakthrough Aurase Wound Gel by SolasCure for chronic wounds. BRAIN BioIncubator segment thrives -
PRESS RELEASE
AUTO1 Group achieves record-breaking 2025 results, delivering all-time highs in units sold, gross profit and adjusted EBITDA
AUTO1 Group announces record-breaking 2025 results with all-time highs in units sold, gross profit, and adjusted EBITDA. Full-year and Q4 2025 performance highlighted -
-
-
-
PRESS RELEASE
Sandoz delivers strong full-year results; guidance for 2026 reflects an expected acceleration in growth
Sandoz reports strong full-year results for 2025 with net sales growth and core EBITDA margin expansion. The guidance for 2026 anticipates further growth in net sales and core EBITDA margin -
-
PRESS RELEASE
Nordex Group reports solid Q4/2025 results, enabling the company to meet all financial and operational targets for 2025 and to exceed its previously communicated mid‑term EBITDA margin target
Nordex Group reports solid Q4/2025 results, meeting and exceeding financial and operational targets. New mid-term EBITDA margin target set at 10-12%. Sales expected to be EUR 8.2-9.0 billion for 2026 -
REGULATED PRESS RELEASE
2025 results. Solid performance in an unstable environment. Operating margin: 19.5% - Net margin: 14.1% - Dividend per share: €1.05
Interparfums reports solid performance in 2025 despite external challenges, maintaining high margins. Financial results show stable operating and net margins
